This page shows ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Thin returns on a vast asset base and heavy liability funding make this business run on balance-sheet turns.
FY2025's0.2% return on assets became4.0% return on equity, showing how a liability-funded balance sheet magnifies very thin asset returns at the shareholder level. That same structure creates cash conversion volatility: operating cash flow flipped from-$27.1B in FY2024 to$24.6B in FY2025, so liquidity is being driven as much by funding movements as by reported earnings.
Scale has returned faster than earning efficiency; revenue climbed from
Capital is not compounding internally: retained earnings moved from
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's revenue grew 12.7% year-over-year to $47.7B, a solid pace of expansion. This earns a growth score of 65/100.
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B has elevated debt relative to equity (D/E of 17.13), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B generates a 4.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 19/100. This is up from 1.6% the prior year.
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B generates $6.89 in operating cash flow ($24.6B OCF vs $3.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B generated $47.7B in revenue in fiscal year 2025. This represents an increase of 12.7% from the prior year.
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B reported $3.6B in net income in fiscal year 2025. This represents an increase of 132.6% from the prior year.
Cash & Balance Sheet
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B held $231.0B in cash against $0 in long-term debt as of fiscal year 2025.
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B had 3.86B shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's net profit margin was 7.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.9 percentage points from the prior year.
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's ROE was 4.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.4 percentage points from the prior year.
Capital Allocation
HDLB Income Statement
| Metric | Q4'25 | Q2'25 | Q1'25 | Q4'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $11.6B-4.3% | $12.2B | N/A | $9.9B+8.7% | $9.1B | N/A | $8.5B |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | $37.0M+5.7% | $35.0M | N/A | $29.0M+31.8% | $22.0M | N/A | $25.0M |
| Income Tax | N/A | -$336.0M-210.9% | $303.0M | N/A | $28.0M-92.3% | $366.0M | N/A | $332.0M |
| Net Income | N/A | $1.2B+15.7% | $1.0B | N/A | -$224.0M-122.1% | $1.0B | N/A | $1.1B |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
HDLB Balance Sheet
| Metric | Q4'25 | Q2'25 | Q1'25 | Q4'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.6T-3.3% | $1.7T+8.0% | $1.5T-1.3% | $1.6T+0.2% | $1.6T+40.1% | $1.1T-3.4% | $1.2T0.0% | $1.2T |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $231.0B-10.6% | $258.3B | N/A | $243.4B-12.3% | $277.5B | N/A | $190.5B+5.3% | $181.0B |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $6.6B-2.3% | $6.8B+0.9% | $6.7B+2.9% | $6.5B-7.4% | $7.0B+12.6% | $6.2B+4.0% | $6.0B-4.5% | $6.3B |
| Total Liabilities | $1.5T-3.1% | $1.6T+8.7% | $1.5T-1.6% | $1.5T+0.2% | $1.5T+38.5% | $1.1T-3.5% | $1.1T+5.5% | $1.0T |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $89.2B-6.0% | $94.9B-2.3% | $97.1B+2.6% | $94.7B+0.4% | $94.2B+70.2% | $55.4B-0.4% | $55.6B+4.3% | $53.3B |
| Retained Earnings | -$2.1B-158.0% | $3.7B-59.4% | $9.1B+16.5% | $7.8B+5.7% | $7.4B-74.6% | $29.2B+3.5% | $28.2B+1.5% | $27.8B |
HDLB Cash Flow Statement
| Metric | Q4'25 | Q2'25 | Q1'25 | Q4'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
HDLB Financial Ratios
| Metric | Q4'25 | Q2'25 | Q1'25 | Q4'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | 10.3%+1.8pp | 8.5% | N/A | -2.3%-13.4pp | 11.1% | N/A | 13.3% |
| Return on Equity | N/A | 1.3%+0.2pp | 1.1% | N/A | -0.2%-2.1pp | 1.8% | N/A | 2.1% |
| Return on Assets | N/A | 0.1%0.0pp | 0.1% | N/A | -0.0%-0.1pp | 0.1% | N/A | 0.1% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 17.13+0.5 | 16.63+1.7 | 14.93-0.6 | 15.56-0.0 | 15.60-3.6 | 19.17-0.6 | 19.80+0.2 | 19.58 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
What is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's annual revenue?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) reported $47.7B in total revenue for fiscal year 2025. This represents a 12.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's revenue growing?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) revenue grew by 12.7% year-over-year, from $42.3B to $47.7B in fiscal year 2025.
Is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B profitable?
Yes, ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) reported a net income of $3.6B in fiscal year 2025, with a net profit margin of 7.5%.
What is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's net profit margin?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) had a net profit margin of 7.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's return on equity (ROE)?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) has a return on equity of 4.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's operating cash flow?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) generated $24.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's total assets?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) had $1.6T in total assets as of fiscal year 2025, including both current and long-term assets.
What is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's debt-to-equity ratio?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) had a debt-to-equity ratio of 17.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's return on assets (ROA)?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) had a return on assets of 0.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's Piotroski F-Score?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B's earnings high quality?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) has an earnings quality ratio of 6.89x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B?
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) scores 14 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.